Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-02-27 @ 10:38 AM
Study NCT ID:
NCT03112694
Status:
COMPLETED
Last Update Posted:
2020-06-02
First Post:
2017-04-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors
Sponsor:
Ipsen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A-US-52030-364
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None